Co-created the concept and execution plan for an innovative unbranded Inflammatory Bowel Disease (IBD) disease education resource, leveraging collaborative ideation and strategic planning to address educational needs effectively.Crafted and executed tailored engagement strategies for key opinion leaders (KOLs), aligning with the IBD Strategy team’s objectives. Leveraged insights into the preferences of KOLs to actively involve them in developing a new unbranded IBD education website and other key initiatives, fostering collaboration and endorsement.Lead impactful cross-functional working group on diversity, equity and inclusion (DEI) and health equity, driving collaborative initiatives and meaningful results.Spearheaded acclaimed IBD training sessions for sales leaders at a top academic center.

Gastroenterology - IBD and rare disease; focus on contracting, population health, strategy and execution of key account plans. Extensive work with KOLs & C & D Suite.

Strategize and execute projects through cross-functional collaboration with legal, compliance, medical, leadership, internal production, external vendors

Lead in top IBD accounts with goal of removing barriers & positioning myself and Takeda as a valued partner in IBD. Primary point of contact in key IOI accounts, academic centers & hospitals in Florida & South Georgia. Responsible for contracting; developing, executing and adapting account strategies & coordinating team execution internally across functional areas to meet customer needs.

Launched humanized monoclonal antibody IV infusion for the treatment of Ulcerative Colitis & Crohn's Disease. Call on gastroenterologists, oncology centers, hospitals, infusion centers and academic institutions. Launched buy & bill product with a misc. j-code.